• Aslan AT, Tanriverdi ES, Kaya SY, Dalgan G, Saltoğlu N, Yılmaz E, Çiçek Y, Yılmaz M, Erol Ç, Azap ÖK, Hazırolan G, Dağ O, Yüce ZT, Sagiroglu P, Boztaş D, Işık MC, Otlu B, Harris PNA, Paterson DL, Akova M; Study Group for Carbapenem Resistance (SCARE). Comparison of ceftazidime-avibactam with other appropriate antimicrobial therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections in Türkiye: A multi-centre retrospective matched-cohort study. Int J Antimicrob Agents. 2026 Jan;67(1):107650.

           https://pubmed.ncbi.nlm.nih.gov/41161581/

• Boşnak C, Akova M. Sepsis in the older intensive care unit patient: current insights and nursing priorities. Intensive Crit Care Nurs. 2026 Feb;92:104249.

           https://pubmed.ncbi.nlm.nih.gov/41092594/

• Tas A, Silindir-Günay M, Calamak S, Nigiz S, Inkaya AC. Development, characterization, and in vitro evaluation of co-drug encapsulated, targeted theranostic liposomes for osteomyelitis. J Radioanal Nuclear Chem, Jan 12,2026. 

           https://doi.org/10.1007/s10967-025-10708-9

• Buran S, Tüfekçi O, Sarı EO, Damar-Örenler S, Damar-Çakırca T, Akgöz A, Besler-Tuncer A, Yakut Y, Karaca NB, Uzun M, Sönmezer MÇ, İnkaya AÇ, Ünal S, Ünal E. Assessing biopsychosocial status in people living with HIV: validity, reliablity, and respnsiveness of BETY-BQ. BMC Infect Dis Jan 12, 2026. 

           https://pubmed.ncbi.nlm.nih.gov/41526851/

• Tanriover MD, Poulimeneas D, Tsopela GC, Kopsidas I, Argyropoulos C, Di Marzo R, Valdenmaiier O, Jakobsen SF, Valle Simon P, Carcas-Sansuan AJ, Olesen OF, Cornely OA, Pana ZD, Zaoutis T, Akova M. Barriers and Opportunities to Include Underrepresented Population Groups in Vaccine Trials: Cross-Sectional, Observational, Online Survey Study From the VACCELERATE Research Network. JMIR Public Health Surveill. 2026 Apr 7;12:e89025.

           https://pubmed.ncbi.nlm.nih.gov/41945868/

• Ergönül Ö, Akova M. Influenza Pandemics After COVID-19: Still a Credible Threat in a Broader Pandemic Landscape. Infect Dis Clin Microbiol. 2026 Jan 30;8(1):120-122.

           https://pubmed.ncbi.nlm.nih.gov/41809928/

• Stemler J, Yeghiazaryan L, Stephan C, Greve-Isdahl Mohn K, Cox RJ, Carcas-Sansuan AJ, Romero Rodriguez E, Moltó J, Vergara Mitxeltorena I, Pink I, Welte T, Zablockienė B, Akova M, Bethe U, Grimm S, Salmanton-García J, Jakobs J, Tischmann L, Zarrouk M, Cüppers A, Biehl LM, Grothe J, Mellinghoff SC, Nacov JA, Neuhann JM, Sprute R, Frías-Iniesta J, Negi R, Gaillard C, Saini G, León AG, Mallon PWG, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Posch M, Koehler P, Cornely OA; EU-COVAT-1 AGED study group on behalf of the VACCELERATE Consortium. Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report. Int J Infect Dis. 2026 Apr;165:108466. 

           https://pubmed.ncbi.nlm.nih.gov/41655623/

• Klyasova G, Solopova G, Abdalla J, Popova M, Ar MC, Sungur M, Fakih RE, Almaghrabi RS, Akova M. Early Antifungal Treatment in Immunocompromised Patients, Including Hematological and Critically Ill Patients. J Fungi (Basel). 2026 Jan 13;12(1):59.

           https://pubmed.ncbi.nlm.nih.gov/41590471/

• Balaban U, Kara E, Pinar A, Gulmez D, Aladag Karakulak E, Arikan Akdagli S, Uzun O, Metan G. Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center Analysis. Indian J Hematol Blood Transfus. 2026 May;42(3):818-825.

            https://pubmed.ncbi.nlm.nih.gov/42040675/

• Kara E, Sahin N, Yumrucu FG, Metan G. Pharmacist involvement in antifungal stewardship programs: a systematic review of clinical, utilization, and economic outcomes. Int J Clin Pharm. 2026 Apr 24.

           https://pubmed.ncbi.nlm.nih.gov/42029838/

• Akman Ar ED, Kara E, Karadoğan E, Ozdede M, Pınar A, Uzun O, Metan G. Towards precision antibiotic therapy: predictors and outcomes of meropenem target attainment. Eur J Hosp Pharm. 2026 Mar 27:ejhpharm-2026-004940.

           https://pubmed.ncbi.nlm.nih.gov/41895816/

• Işık MC, Telli Dizman G, Gül ND, Tekin Demir İ, Aytaç Ak H, Zarakolu P, Metan G. Safety of discontinuing contact precautions in patients with multidrug-resistant bacterial infection or colonization. Acta Microbiol Immunol Hung. 2026 Mar 20:030.2026.02900.

           https://pubmed.ncbi.nlm.nih.gov/41860595/

• Ozturk E, Bali EA, Kiymaz YC, Tepe D, Can IN, Kaya A, Bolataslan BA, Bosnak C, Cunetoglu B, Karasin F, Kutay H, Pekguzel M, Buyukkoruk M, Kuzi S, Usta BA, Agaoglu Y, Irkoren P, Aydın M, Kizmaz YU, Verendag D, Durmusoglu LM, Sonmezer MC, Suntur BM, Parlayan HNK, Kutlu SS, Cinar G, Memikoglu KO, Yavuz SS, Kaya SY, Akhan S, Ergonul O.Clinical and microbiological characteristics of Nocardia infections: a 10-Year multicentre study from Türkiye. Eur J Clin Microbiol Infect Dis. 2026 Mar 25.

           https://pubmed.ncbi.nlm.nih.gov/41879939/

• İnan A, Sayın-Kutlu S, Sönmezer MÇ, Gökengin D.Highlights on HIV Prevention and Antiretroviral Therapy from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 and Expectations from CROI 2026. Infect Dis Clin Microbiol. 2026 Jan 30;8(1):14-25

           https://pubmed.ncbi.nlm.nih.gov/41809923/

• Akdogan N, Kaymak MK, Bosnak C, Sonmezer MC, Gulmez D, Polat C, Akdagli SA. Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae, From Türkiye. Int J Dermatol. 2026 Jan.

           https://pubmed.ncbi.nlm.nih.gov/41514458/

• Özdemirel HÖ, Tahravi H, Kucukyildirim S, İnkaya AÇ, Mergen H. A novel jumbo phage infecting Pseudomonas aeruginosa: genomic insights and phylogenetic classification. Arch Microbiol. 2026 Apr 24;208(7):357.

           https://pubmed.ncbi.nlm.nih.gov/42029752/